Mitigating adverse pregnancy and neonatal outcomes through expanded carrier screening in an oocyte donation programme
Reproductive BioMedicine Online · 2025
DOI: 10.1016/j.rbmo.2024.104744 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Reproductive BioMedicine Online, 2025. Verfasst von Gabriela Palacios-Verdú und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dexeus Fertility, Department of Obstetrics Gynecology and Reproductive Medicine, Hospital Universitari Dexeus, Barcelona, Spain. Electronic address: …. Hauptthemen laut MEDLINE: Oocyte Donation, Pregnancy Outcome, Genetic Carrier Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Universitat Autònoma de Barcelona, European Commission.
Abstract (Originalsprache)
RESEARCH QUESTION: How frequent are adverse outcomes in an oocyte donation programme, and how many recessive conditions can be prevented by implementing expanded carrier screening (ECS)? DESIGN: This retrospective observational study used data from oocyte donation cycles between January 2014 and December 2021 at the Reproductive Medicine Unit of a University Hospital in Spain. Adverse outcomes were studied in 4565 oocyte donation cycles assigned as low-risk at the time of genetic matching. The number of high-risk assignations was identified when ECS was applied to the oocyte donor and recipient's male partner (or sperm donor for double donation). RESULTS: Of 4565 oocyte donation cycles, 67 recipients (1.47%) reported an adverse obstetric or neonatal outcome. A genetic aetiology was confirmed in 25 (37.3%). The remaining 42 (62.7%) cases included congenital malformations, neurodevelopmental disorders and other conditions with unknown genetic origins. Moreover, 211 (4.6%, 211/4565) high-risk assignations were identified where both the oocyte donor and recipient's male partner were carriers of the same autosomal recessive condition. This could have led to an additional 1.15% of children born with an autosomal recessive condition (25% × 4.6%). Additionally, 52 (2.8%, 52/1875) oocyte donor candidates were carriers of X-linked conditions, which would have led to an additional 0.7% (25% × 2.8%) being born with an X-Linked disorder. ECS implementation resulted in a 55.7% reduction in adverse outcome risk, from a potential rate of 3.32% (1.47% + 1.15% + 0.7%) to an actual incidence of 1.47%. CONCLUSIONS: ECS reduces the probability that children born from oocyte donation will inherit the recessive conditions screened for. However, certain adverse outcomes remain unavoidable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dexeus Fertility, Department of Obstetrics Gynecology and Reproductive Medicine, Hospital Universitari Dexeus, Barcelona, Spain. Electronic address: gabpal@dexeus.com.
- Dexeus Fertility, Department of Obstetrics Gynecology and Reproductive Medicine, Hospital Universitari Dexeus, Barcelona, Spain.
- Dexeus Fertility, Department of Obstetrics Gynecology and Reproductive Medicine, Hospital Universitari Dexeus, Barcelona, Spain; Nantes Université, Inserm, CR2TI, Nantes and CHU Nantes, Service Biologie de la Reproducti…
- Dexeus Fertility, Department of Obstetrics Gynecology and Reproductive Medicine, Hospital Universitari Dexeus, Barcelona, Spain; Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Förderung
- Universitat Autònoma de Barcelona
- European Commission
Zitieren
APA
Palacios-Verdú, G., Clua, E., Sumarroca, M., Roca-Feliu, M., Freour, T., & Polyzos, N. P. (2025). Mitigating adverse pregnancy and neonatal outcomes through expanded carrier screening in an oocyte donation programme. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2024.104744
Vancouver
Palacios-Verdú G, Clua E, Sumarroca M, Roca-Feliu M, Freour T, Polyzos NP. Mitigating adverse pregnancy and neonatal outcomes through expanded carrier screening in an oocyte donation programme. Reproductive BioMedicine Online. 2025. doi:10.1016/j.rbmo.2024.104744
BibTeX
@article{PalaciosVerd2025,
author = {Palacios-Verdú, Gabriela and Clua, Elisabet and Sumarroca, Marina and Roca-Feliu, Marta and Freour, Thomas and Polyzos, Nikolaos P},
title = {Mitigating adverse pregnancy and neonatal outcomes through expanded carrier screening in an oocyte donation programme},
journal = {Reproductive BioMedicine Online},
year = {2025},
doi = {10.1016/j.rbmo.2024.104744}
}
EUVIMED